Previous Article | Next Article 
Molecular and Cellular Biology, April 2001, p. 2891-2905, Vol. 21, No. 8
0270-7306/01/$04.00+0 DOI: 10.1128/MCB.21.8.2891-2905.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
runt Homology Domain Transcription
Factors (Runx, Cbfa, and AML) Mediate Repression of the Bone
Sialoprotein Promoter: Evidence for Promoter Context-Dependent
Activity of Cbfa Proteins
Amjad
Javed,1
George L.
Barnes,2
B. O.
Jasanya,1
Janet L.
Stein,1
Louis
Gerstenfeld,2
Jane B.
Lian,1 and
Gary S.
Stein1,*
Department of Cell Biology and Cancer Center,
University of Massachusetts Medical School, Worcester,
Massachusetts,1 01655-0106 and
Musculoskeletal Research Laboratories, Department of
Orthopaedic Surgery, Boston University Medical Center, Boston,
Massachusetts2 02118-2526
Received 16 November 2000/Accepted 22 January 2001
Expression of the bone sialoprotein (BSP) gene, a marker of bone
formation, is largely restricted to cells in mineralized tissues.
Recent studies have shown that the Cbfa1 (also known as Runx2, AML-3,
and PEBP2
A) transcription factor supports commitment and
differentiation of progenitor cells to hypertrophic chondrocytes and
osteoblasts. This study addresses the functional involvement of Cbfa
sites in expression of the Gallus BSP gene. Gel mobility shift analyses with nuclear extracts from ROS 17/2.8 osteoblastic cells
revealed that multiple Cbfa consensus sequences are functional Cbfa DNA
binding sites. Responsiveness of the 1.2-kb Gallus BSP promoter to Cbfa factors Cbfa1, Cbfa2, and Cbfa3 was assayed in osseous
and nonosseous cells. Each of the Cbfa factors mediated repression of
the wild-type BSP promoter, in contrast to their well known activation
of various hematopoietic and skeletal phenotypic genes. Suppression of
BSP by Cbfa factors was not observed in BSP promoters in which Cbfa
sites were deleted or mutated. Expression of the endogenous BSP gene in
Gallus osteoblasts was similarly downregulated by forced
expression of Cbfa factors. Our data indicate that Cbfa repression of
the BSP promoter does not involve the transducin-like enhancer (TLE)
proteins. Neither coexpression of TLE1 or TLE2 nor the absence of the
TLE interaction motif of Cbfa1 (amino acids 501 to 513) influenced
repressor activity. However, removal of the C terminus of Cbfa1 (amino
acids 362 to 513) relieved suppression of the BSP promoter. Our
results, together with the evolutionary conservation of the seven Cbfa
sites in the Gallus and human BSP promoters, suggest that
suppressor activity by Cbfa is of significant physiologic consequence
and may contribute to spatiotemporal expression of BSP during bone development.
*
Corresponding author. Mailing address: Department of
Cell Biology, University of Massachusetts Medical School, 55 Lake Ave. North, Worcester, MA 01655-0106. Phone: (508) 856-5625. Fax: (508) 856-6800. E-mail: Gary.Stein{at}umassmed.edu.
Molecular and Cellular Biology, April 2001, p. 2891-2905, Vol. 21, No. 8
0270-7306/01/$04.00+0 DOI: 10.1128/MCB.21.8.2891-2905.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Zhang, C.Y., Zheng, S.G., Wang, Y.X., Zhu, J.X., Zhu, X., Zhao, Y.M., Ge, L.H.
(2009). Novel RUNX2 Mutations in Chinese Individuals with Cleidocranial Dysplasia. JDR
88: 861-866
[Abstract]
[Full Text]
-
Li, Y., Pan, W., Xu, W., He, N., Chen, X., Liu, H., Darryl Quarles, L., Zhou, H., Xiao, Z.
(2009). RUNX2 mutations in Chinese patients with cleidocranial dysplasia. Mutagenesis
24: 425-431
[Abstract]
[Full Text]
-
Sun, X., Wei, L., Chen, Q., Terek, R. M.
(2009). HDAC4 Represses Vascular Endothelial Growth Factor Expression in Chondrosarcoma by Modulating RUNX2 Activity. J. Biol. Chem.
284: 21881-21890
[Abstract]
[Full Text]
-
Sharff, K. A., Song, W.-X., Luo, X., Tang, N., Luo, J., Chen, J., Bi, Y., He, B.-C., Huang, J., Li, X., Jiang, W., Zhu, G.-H., Su, Y., He, Y., Shen, J., Wang, Y., Chen, L., Zuo, G.-W., Liu, B., Pan, X., Reid, R. R., Luu, H. H., Haydon, R. C., He, T.-C.
(2009). Hey1 Basic Helix-Loop-Helix Protein Plays an Important Role in Mediating BMP9-induced Osteogenic Differentiation of Mesenchymal Progenitor Cells. J. Biol. Chem.
284: 649-659
[Abstract]
[Full Text]
-
Matsubara, T., Kida, K., Yamaguchi, A., Hata, K., Ichida, F., Meguro, H., Aburatani, H., Nishimura, R., Yoneda, T.
(2008). BMP2 Regulates Osterix through Msx2 and Runx2 during Osteoblast Differentiation. J. Biol. Chem.
283: 29119-29125
[Abstract]
[Full Text]
-
Javed, A., Bae, J.-S., Afzal, F., Gutierrez, S., Pratap, J., Zaidi, S. K., Lou, Y., van Wijnen, A. J., Stein, J. L., Stein, G. S., Lian, J. B.
(2008). Structural Coupling of Smad and Runx2 for Execution of the BMP2 Osteogenic Signal. J. Biol. Chem.
283: 8412-8422
[Abstract]
[Full Text]
-
Lamour, V., Detry, C., Sanchez, C., Henrotin, Y., Castronovo, V., Bellahcene, A.
(2007). Runx2- and Histone Deacetylase 3-mediated Repression Is Relieved in Differentiating Human Osteoblast Cells to Allow High Bone Sialoprotein Expression. J. Biol. Chem.
282: 36240-36249
[Abstract]
[Full Text]
-
Wang, Q., Wei, X., Zhu, T., Zhang, M., Shen, R., Xing, L., O'Keefe, R. J., Chen, D.
(2007). Bone Morphogenetic Protein 2 Activates Smad6 Gene Transcription through Bone-specific Transcription Factor Runx2. J. Biol. Chem.
282: 10742-10748
[Abstract]
[Full Text]
-
Fu, Q., Manolagas, S. C., O'Brien, C. A.
(2006). Parathyroid Hormone Controls Receptor Activator of NF-{kappa}B Ligand Gene Expression via a Distant Transcriptional Enhancer.. Mol. Cell. Biol.
26: 6453-6468
[Abstract]
[Full Text]
-
Wai, P. Y., Mi, Z., Gao, C., Guo, H., Marroquin, C., Kuo, P. C.
(2006). Ets-1 and Runx2 Regulate Transcription of a Metastatic Gene, Osteopontin, in Murine Colorectal Cancer Cells. J. Biol. Chem.
281: 18973-18982
[Abstract]
[Full Text]
-
Shen, R., Wang, X., Drissi, H., Liu, F., O'Keefe, R. J., Chen, D.
(2006). Cyclin D1-Cdk4 Induce Runx2 Ubiquitination and Degradation. J. Biol. Chem.
281: 16347-16353
[Abstract]
[Full Text]
-
Shen, R., Chen, M., Wang, Y.-J., Kaneki, H., Xing, L., O'Keefe, R. J., Chen, D.
(2006). Smad6 Interacts with Runx2 and Mediates Smad Ubiquitin Regulatory Factor 1-induced Runx2 Degradation. J. Biol. Chem.
281: 3569-3576
[Abstract]
[Full Text]
-
Shen, Q., Christakos, S.
(2005). The Vitamin D Receptor, Runx2, and the Notch Signaling Pathway Cooperate in the Transcriptional Regulation of Osteopontin. J. Biol. Chem.
280: 40589-40598
[Abstract]
[Full Text]
-
Gaur, T., Lengner, C. J., Hovhannisyan, H., Bhat, R. A., Bodine, P. V. N., Komm, B. S., Javed, A., van Wijnen, A. J., Stein, J. L., Stein, G. S., Lian, J. B.
(2005). Canonical WNT Signaling Promotes Osteogenesis by Directly Stimulating Runx2 Gene Expression. J. Biol. Chem.
280: 33132-33140
[Abstract]
[Full Text]
-
Chen, S., Rani, S., Wu, Y., Unterbrink, A., Gu, T. T., Gluhak-Heinrich, J., Chuang, H.-H., MacDougall, M.
(2005). Differential Regulation of Dentin Sialophosphoprotein Expression by Runx2 during Odontoblast Cytodifferentiation. J. Biol. Chem.
280: 29717-29727
[Abstract]
[Full Text]
-
Javed, A., Barnes, G. L., Pratap, J., Antkowiak, T., Gerstenfeld, L. C., van Wijnen, A. J., Stein, J. L., Lian, J. B., Stein, G. S.
(2005). Impaired intranuclear trafficking of Runx2 (AML3/CBFA1) transcription factors in breast cancer cells inhibits osteolysis in vivo. Proc. Natl. Acad. Sci. USA
102: 1454-1459
[Abstract]
[Full Text]
-
Schroeder, T. M., Kahler, R. A., Li, X., Westendorf, J. J.
(2004). Histone Deacetylase 3 Interacts with Runx2 to Repress the Osteocalcin Promoter and Regulate Osteoblast Differentiation. J. Biol. Chem.
279: 41998-42007
[Abstract]
[Full Text]
-
Barnes, G. L., Hebert, K. E., Kamal, M., Javed, A., Einhorn, T. A., Lian, J. B., Stein, G. S., Gerstenfeld, L. C.
(2004). Fidelity of Runx2 Activity in Breast Cancer Cells Is Required for the Generation of Metastases-Associated Osteolytic Disease. Cancer Res.
64: 4506-4513
[Abstract]
[Full Text]
-
Bertrand-Philippe, M., Ruddell, R. G., Arthur, M. J. P., Thomas, J., Mungalsingh, N., Mann, D. A.
(2004). Regulation of Tissue Inhibitor of Metalloproteinase 1 Gene Transcription by RUNX1 and RUNX2. J. Biol. Chem.
279: 24530-24539
[Abstract]
[Full Text]
-
Slobedman, B., Stern, J. L., Cunningham, A. L., Abendroth, A., Abate, D. A., Mocarski, E. S.
(2004). Impact of Human Cytomegalovirus Latent Infection on Myeloid Progenitor Cell Gene Expression. J. Virol.
78: 4054-4062
[Abstract]
[Full Text]
-
Sevetson, B., Taylor, S., Pan, Y.
(2004). Cbfa1/RUNX2 Directs Specific Expression of the Sclerosteosis Gene (SOST). J. Biol. Chem.
279: 13849-13858
[Abstract]
[Full Text]
-
McCarthy, T. L., Chang, W.-Z., Liu, Y., Centrella, M.
(2003). Runx2 Integrates Estrogen Activity in Osteoblasts. J. Biol. Chem.
278: 43121-43129
[Abstract]
[Full Text]
-
Enomoto, H., Shiojiri, S., Hoshi, K., Furuichi, T., Fukuyama, R., Yoshida, C. A., Kanatani, N., Nakamura, R., Mizuno, A., Zanma, A., Yano, K., Yasuda, H., Higashio, K., Takada, K., Komori, T.
(2003). Induction of Osteoclast Differentiation by Runx2 through Receptor Activator of Nuclear Factor-{kappa}B Ligand (RANKL) and Osteoprotegerin Regulation and Partial Rescue of Osteoclastogenesis in Runx2-/- Mice by RANKL Transgene. J. Biol. Chem.
278: 23971-23977
[Abstract]
[Full Text]
-
Zhao, M., Berry, J.E., Somerman, M.J.
(2003). Bone Morphogenetic Protein-2 Inhibits Differentiation and Mineralization of Cementoblasts in vitro. JDR
82: 23-27
[Abstract]
[Full Text]
-
Westendorf, J. J., Zaidi, S. K., Cascino, J. E., Kahler, R., van Wijnen, A. J., Lian, J. B., Yoshida, M., Stein, G. S., Li, X.
(2002). Runx2 (Cbfa1, AML-3) Interacts with Histone Deacetylase 6 and Represses the p21CIP1/WAF1 Promoter. Mol. Cell. Biol.
22: 7982-7992
[Abstract]
[Full Text]
-
Harrington, K. S., Javed, A., Drissi, H., McNeil, S., Lian, J. B., Stein, J. L., van Wijnen, A. J., Wang, Y.-L., Stein, G. S.
(2002). Transcription factors RUNX1/AML1 and RUNX2/Cbfa1 dynamically associate with stationary subnuclear domains. J. Cell Sci.
115: 4167-4176
[Abstract]
[Full Text]
-
Banerjee, C., Javed, A., Choi, J.-Y., Green, J., Rosen, V., van Wijnen, A. J., Stein, J. L., Lian, J. B., Stein, G. S.
(2001). Differential Regulation of the Two Principal Runx2/Cbfa1 N-Terminal Isoforms in Response to Bone Morphogenetic Protein-2 during Development of the Osteoblast Phenotype. Endocrinology
142: 4026-4039
[Abstract]
[Full Text]
-
Zaidi, S. K., Javed, A., Choi, J.-Y., van Wijnen, A. J., Stein, J. L., Lian, J. B., Stein, G. S.
(2001). A specific targeting signal directs Runx2/Cbfa1 to subnuclear domains and contributes to transactivation of the osteocalcin gene. J. Cell Sci.
114: 3093-3102
[Abstract]
[Full Text]
-
Gilbert, L., He, X., Farmer, P., Rubin, J., Drissi, H., van Wijnen, A. J., Lian, J. B., Stein, G. S., Nanes, M. S.
(2002). Expression of the Osteoblast Differentiation Factor RUNX2 (Cbfa1/AML3/Pebp2alpha A) Is Inhibited by Tumor Necrosis Factor-alpha. J. Biol. Chem.
277: 2695-2701
[Abstract]
[Full Text]
-
Gutierrez, S., Javed, A., Tennant, D. K., van Rees, M., Montecino, M., Stein, G. S., Stein, J. L., Lian, J. B.
(2002). CCAAT/Enhancer-binding Proteins (C/EBP) beta and delta Activate Osteocalcin Gene Transcription and Synergize with Runx2 at the C/EBP Element to Regulate Bone-specific Expression. J. Biol. Chem.
277: 1316-1323
[Abstract]
[Full Text]
-
Choi, J.-Y., Pratap, J., Javed, A., Zaidi, S. K., Xing, L., Balint, E., Dalamangas, S., Boyce, B., van Wijnen, A. J., Lian, J. B., Stein, J. L., Jones, S. N., Stein, G. S.
(2001). Subnuclear targeting of Runx/Cbfa/AML factors is essential for tissue-specific differentiation during embryonic development. Proc. Natl. Acad. Sci. USA
98: 8650-8655
[Abstract]
[Full Text]